AU629048B2 - N-(-4-(phenyl)-1,2-dihydro-3-quinolyl)-N'-(phenyl) urea derivatives and their use - Google Patents
N-(-4-(phenyl)-1,2-dihydro-3-quinolyl)-N'-(phenyl) urea derivatives and their useInfo
- Publication number
- AU629048B2 AU629048B2 AU63707/90A AU6370790A AU629048B2 AU 629048 B2 AU629048 B2 AU 629048B2 AU 63707/90 A AU63707/90 A AU 63707/90A AU 6370790 A AU6370790 A AU 6370790A AU 629048 B2 AU629048 B2 AU 629048B2
- Authority
- AU
- Australia
- Prior art keywords
- phenyl
- quinolyl
- dihydro
- chem
- urea derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- OUJIBGNLZGAJAG-UHFFFAOYSA-N 1-phenyl-3-(4-phenyl-1,2-dihydroquinolin-3-yl)urea Chemical class C1(=CC=CC=C1)C1=C(CNC2=CC=CC=C12)NC(=O)NC1=CC=CC=C1 OUJIBGNLZGAJAG-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 102000001494 Sterol O-Acyltransferase Human genes 0.000 abstract 1
- 108010054082 Sterol O-acyltransferase Proteins 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Measurement Of Radiation (AREA)
- Holo Graphy (AREA)
- Detergent Compositions (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26278289 | 1989-10-06 | ||
| JP1-262782 | 1989-10-06 | ||
| JP32229089 | 1989-12-11 | ||
| JP1-322290 | 1989-12-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU6370790A AU6370790A (en) | 1991-04-11 |
| AU629048B2 true AU629048B2 (en) | 1992-09-24 |
Family
ID=26545706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU63707/90A Ceased AU629048B2 (en) | 1989-10-06 | 1990-09-28 | N-(-4-(phenyl)-1,2-dihydro-3-quinolyl)-N'-(phenyl) urea derivatives and their use |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5223513A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0421456B1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR910007883A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1050715A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE116301T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU629048B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2026890C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69015541T2 (cg-RX-API-DMAC7.html) |
| FI (1) | FI904915A7 (cg-RX-API-DMAC7.html) |
| HU (1) | HUT55364A (cg-RX-API-DMAC7.html) |
| IE (1) | IE903454A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL95839A (cg-RX-API-DMAC7.html) |
| NO (1) | NO904300L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ235582A (cg-RX-API-DMAC7.html) |
| PT (1) | PT95515A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2001910C1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW205037B (cg-RX-API-DMAC7.html) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03181465A (ja) * | 1989-12-11 | 1991-08-07 | Takeda Chem Ind Ltd | キノリン誘導体 |
| AU1879792A (en) * | 1991-04-26 | 1992-12-21 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)quinoline derivatives |
| DK0623112T3 (da) * | 1992-01-23 | 1999-08-30 | Pfizer | 4-phenyl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinolinderivater som antihypercholesterolæmiske og antiatherosclerotiske mi |
| TW241258B (cg-RX-API-DMAC7.html) * | 1992-04-15 | 1995-02-21 | Takeda Pharm Industry Co Ltd | |
| AU4028393A (en) * | 1992-05-28 | 1993-12-30 | Pfizer Inc. | New (N)-aryl and (N)-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (ACAT) |
| EP0585913B1 (en) * | 1992-09-04 | 1997-12-29 | Takeda Chemical Industries, Ltd. | Condensed heterocyclic compounds, their production and use |
| US5565472A (en) * | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| NZ264063A (en) * | 1993-08-13 | 1995-11-27 | Nihon Nohyaku Co Ltd | N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions |
| TW263498B (cg-RX-API-DMAC7.html) * | 1993-11-10 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
| US6133326A (en) | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
| US5843957A (en) * | 1995-05-19 | 1998-12-01 | Sumitomo Pharmaceuticals Company, Ltd. | Naphthyridine derivatives |
| WO1999009983A1 (en) * | 1997-08-28 | 1999-03-04 | Bristol-Myers Squibb Company | 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators |
| US6452008B2 (en) | 1998-02-25 | 2002-09-17 | Sumitomo Pharmaceuticals Company, Limited | Pyridone derivatives and process for preparing the same |
| CA2321237A1 (en) | 1998-02-25 | 1999-09-02 | Masami Muraoka | Pyridone derivatives and process for producing the same |
| AU755202B2 (en) * | 1998-12-04 | 2002-12-05 | Bristol-Myers Squibb Company | 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| OA12173A (en) | 2000-02-02 | 2006-05-08 | Warner Lambert Co | Dual inhibitors of cholesterol ester and wax estersynthesis for sebaceous gland disorders. |
| WO2002070488A1 (en) * | 2001-03-02 | 2002-09-12 | Sumika Fine Chemicals Co., Ltd. | Process for producing quinoline-3-carboxylic acid compound |
| KR100639745B1 (ko) * | 2001-04-30 | 2006-10-30 | 화이자 프로덕츠 인크. | Ｃｅｔｐ 억제제 제조 방법 |
| WO2005030792A2 (en) | 2003-09-23 | 2005-04-07 | Merck & Co., Inc. | Quinoline potassium channel inhibitors |
| CN103906735B (zh) | 2011-11-04 | 2016-12-07 | 霍夫曼-拉罗奇有限公司 | 新芳基-喹啉衍生物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1216878B (de) * | 1963-04-02 | 1966-05-18 | Cassella Farbwerke Mainkur Ag | Verfahren zur Herstellung von coronargefaesserweiternden Derivaten des 7-Hydroxy-2-oxo-1, 2-dihydrochinolins |
| NO133758C (cg-RX-API-DMAC7.html) * | 1970-04-04 | 1976-06-23 | Takeda Chemical Industries Ltd | |
| JPS555502B1 (cg-RX-API-DMAC7.html) * | 1971-07-31 | 1980-02-07 | ||
| US4530931A (en) * | 1983-01-03 | 1985-07-23 | Usv Pharmaceutical Corp. | 8-Quinoline carbanilates for the inhibition of lipolysis |
| EP0166354B1 (en) * | 1984-06-26 | 1992-08-05 | Merck & Co. Inc. | Benzofused lactam compounds and pharmaceutical compositions containing them |
| IE892088L (en) * | 1988-07-12 | 1990-01-12 | William Henry Deryk Morris | Quinoline derivatives, their production and use |
-
1990
- 1990-09-20 TW TW079107912A patent/TW205037B/zh active
- 1990-09-25 US US07/587,795 patent/US5223513A/en not_active Expired - Fee Related
- 1990-09-25 IE IE345490A patent/IE903454A1/en unknown
- 1990-09-28 IL IL9583990A patent/IL95839A/en not_active IP Right Cessation
- 1990-09-28 AU AU63707/90A patent/AU629048B2/en not_active Ceased
- 1990-10-03 NO NO90904300A patent/NO904300L/no unknown
- 1990-10-04 CA CA002026890A patent/CA2026890C/en not_active Expired - Fee Related
- 1990-10-04 PT PT95515A patent/PT95515A/pt not_active Application Discontinuation
- 1990-10-05 EP EP90119128A patent/EP0421456B1/en not_active Expired - Lifetime
- 1990-10-05 CN CN90108222A patent/CN1050715A/zh active Pending
- 1990-10-05 HU HU906360A patent/HUT55364A/hu unknown
- 1990-10-05 FI FI904915A patent/FI904915A7/fi not_active Application Discontinuation
- 1990-10-05 DE DE69015541T patent/DE69015541T2/de not_active Expired - Fee Related
- 1990-10-05 AT AT90119128T patent/ATE116301T1/de not_active IP Right Cessation
- 1990-10-05 RU SU904831426A patent/RU2001910C1/ru active
- 1990-10-05 NZ NZ235582A patent/NZ235582A/en unknown
- 1990-10-06 KR KR1019900015908A patent/KR910007883A/ko not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU6370790A (en) | 1991-04-11 |
| IE903454A1 (en) | 1991-04-10 |
| NO904300D0 (no) | 1990-10-03 |
| DE69015541D1 (de) | 1995-02-09 |
| FI904915A0 (fi) | 1990-10-05 |
| RU2001910C1 (ru) | 1993-10-30 |
| CA2026890C (en) | 2001-09-18 |
| JPH03223254A (ja) | 1991-10-02 |
| EP0421456A2 (en) | 1991-04-10 |
| ATE116301T1 (de) | 1995-01-15 |
| HU906360D0 (en) | 1991-04-29 |
| US5223513A (en) | 1993-06-29 |
| KR910007883A (ko) | 1991-05-30 |
| HUT55364A (en) | 1991-05-28 |
| PT95515A (pt) | 1991-08-14 |
| DE69015541T2 (de) | 1995-06-01 |
| FI904915A7 (fi) | 1991-04-07 |
| IL95839A0 (en) | 1991-06-30 |
| TW205037B (cg-RX-API-DMAC7.html) | 1993-05-01 |
| NZ235582A (en) | 1992-03-26 |
| NO904300L (no) | 1991-04-08 |
| IL95839A (en) | 1995-03-15 |
| EP0421456B1 (en) | 1994-12-28 |
| EP0421456A3 (en) | 1991-05-29 |
| CA2026890A1 (en) | 1991-04-07 |
| CN1050715A (zh) | 1991-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU629048B2 (en) | N-(-4-(phenyl)-1,2-dihydro-3-quinolyl)-N'-(phenyl) urea derivatives and their use | |
| ATE117681T1 (de) | Chinolinderivate, ihre herstellung und verwendung. | |
| ATE195724T1 (de) | Harnstoff- und amid-derivate mit acat- inhibitorwirkung, ihre herstellung und ihre therapeutische und prophylaktische verwendung | |
| AU8249391A (en) | Sulfonamide derivatives | |
| DE3574968D1 (de) | 11-substituierte-16-phenoxy und 16-phenoxysubstituierte prostatriensaeurederivate. | |
| MX9604398A (es) | Derivados de sulfonamida. | |
| EP0640586A4 (en) | STYLE DERIVATIVES AND ANALOGS AND THEIR USE. | |
| AU3557493A (en) | Photochromatic substances | |
| CS89587A2 (en) | Zpusob vyroby arylcyklobutylalkylaminu | |
| DE69010100D1 (de) | Pyrimidinyl herbizides Mittel. | |
| MY128323A (en) | Thiazole derivatives for inhibition of cytokine production and of cell adhesion | |
| EP0636619A4 (en) | TRICYCLIC HETEROCYCLIC COMPOUNDS. | |
| ATE133672T1 (de) | Thienopyridin-derivate, deren herstellung und verwendung | |
| GB9212000D0 (en) | New synthetic antitumoral compound | |
| AU623500B2 (en) | Carboxylimino benzothiazole derivatives | |
| EP0239064A3 (en) | Herbicidal compounds, their production and use | |
| IE892294L (en) | Cycloalkylthiazole derivatives | |
| DE69624459D1 (de) | Kondensierte indan-derivate und ihre salze | |
| CA2202031A1 (en) | Condensed indan derivatives and salts thereof | |
| EP0443474A3 (en) | 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents |